StockData
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31

Agentix Corp.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$801.34K
P/E (TTM)
–
Dividend yield
–

Agentix Corp. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Agentix does not break out revenue by segment, region or product in the tagged data of its filings for this period type.